1 Min Read
Nov 21 (Reuters) - Starpharma Holdings Ltd
* Vivagel BV for both treatment and prevention of BV has been lodged with U.S. FDA through rolling submission process Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.